Xiaomei Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiaomei Zhang has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Mengqian Li
Department of Internal Medicine of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China
4 shared publicationsYuxin Lai
Department of Internal Medicine of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China
4 shared publicationsHuan Dong
Department of Respiratory Medicine, Changping Hospital of Integrated Chines and Western Medicine, Beijing, China
3 shared publicationsXiaolin Yu
Post-graduate student, China
3 shared publicationsTianshu Yang
Department of Internal Medicine of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China
2 shared publicationsXiaofeng Gu
Department of Internal Medicine of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, P.R. China
2 shared publications
Latest Publications
- Open Access
- 10 March 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Associations between life’s essential 8 and preserved ratio impaired spirometry
Preserved ratio impaired spirometry (PRISm) is a prevalent yet under-researched state of diminished lung function, which has been proposed as a pre-clinical abnormal spirometry associated with chronic obstructive pulmonary disease (COPD) or early-stage COPD. PRISm is closely associated with cardiovascular disease. Preventing and improving quality of life in PRISm subjects is important. We aimed to examined the relationship between American Heart Association’s Life’s Essential 8 (LE8) and PRISm. This cross-sectional study utilized data of 2,869 adults aged ≥ 20 years from the National Health and Nutrition Examination Survey (NHANES) in 2007–2012. Multivariable logistic regression models were employed to examine the association between LE8 score, health behavior score, health factor score, each component of LE8 score, and PRISm. Moreover, the study explored this correlation in greater depth using restricted cubic spline curves and subgroup analyses. Of the 2,869 participants, the mean age was 44.09 ± 0.44 years, and 316 (11.01%) were defined as having PRISm. In fully adjusted models, higher LE8 scores were associated with a reduced odds ratio for PRISm (OR = 0.97; 95% CI, 0.96–0.98). A linear relationship between the LE8 score and PRISm was observed. Similar patterns emerged for health behavior and health factor subscores, with a particularly stronger correlation between health factors and PRISm. In the subgroup analysis, the inverse association between LE8 and PRISm was significantly more pronounced among those with high income. A higher LE8 score was associated with a lower likelihood of developing PRISm. Promoting optimal adherence to the LE8 metrics may improve PRISm and offers a meaningful approach for its prevention and management.
- 10 March 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Open AccessAssociations between life’s essential 8 and preserved ratio impaired spirometry
Preserved ratio impaired spirometry (PRISm) is a prevalent yet under-researched state of diminished lung function, which has been proposed as a pre-clinical abnormal spirometry associated with chronic obstructive pulmonary disease (COPD) or early-stage COPD. PRISm is closely associated with cardiovascular disease. Preventing and improving quality of life in PRISm subjects is important. We aimed to examined the relationship between American Heart Association’s Life’s Essential 8 (LE8) and PRISm. This cross-sectional study utilized data of 2,869 adults aged ≥ 20 years from the National Health and Nutrition Examination Survey (NHANES) in 2007–2012. Multivariable logistic regression models were employed to examine the association between LE8 score, health behavior score, health factor score, each component of LE8 score, and PRISm. Moreover, the study explored this correlation in greater depth using restricted cubic spline curves and subgroup analyses. Of the 2,869 participants, the mean age was 44.09 ± 0.44 years, and 316 (11.01%) were defined as having PRISm. In fully adjusted models, higher LE8 scores were associated with a reduced odds ratio for PRISm (OR = 0.97; 95% CI, 0.96–0.98). A linear relationship between the LE8 score and PRISm was observed. Similar patterns emerged for health behavior and health factor subscores, with a particularly stronger correlation between health factors and PRISm. In the subgroup analysis, the inverse association between LE8 and PRISm was significantly more pronounced among those with high income. A higher LE8 score was associated with a lower likelihood of developing PRISm. Promoting optimal adherence to the LE8 metrics may improve PRISm and offers a meaningful approach for its prevention and management.
- Open Access
- 29 January 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1477730
The infiltration risk prediction models by logistic regression for ground-glass pulmonary nodules: a systematic review and meta-analysis
Methods: CNKI, Wanfang, VIP, Sinomed, Pubmed, Web of Science, Embase, and other databases were searched. The retrieval time was from the establishment of the database to January 31, 2024. We included all predictive models for the invasion of ground-glass pulmonary nodules established. The modeling group was patients with a pathological diagnosis of ground-glass pulmonary nodules. Two researchers screened the literature, established an Excel table for information extraction, used SPSS 25.0 to perform frequency statistics of each independent risk factor, and used Revman 5.4 software for meta-analysis.Results: A total of 29 articles were included, involving 30 independent risk factors, with a cumulative frequency of 99 times. There were 16 risk factors with a frequency of ≥2 times, a total of 85 times, accounting for 85.86%. The meta-analysis showed the following: average CT value (MD = 75.57 HU, 95%CI: 44.40–106.75), maximum diameter (MD = 4.99 mm, 95%CI: 4.22–5.77), vascular convergence sign (OR = 11.16, 95%CI: 6.71–18.56), lobulation sign (OR = 3.80, 95%CI: 1.59–9.09), average diameter (MD = 4.46 mm, 95%CI: 3.44–5.48), maximum CT value (MD = 112.52 HU, 95%CI: 8.08–216.96), spiculation sign (OR = 4.46, 95%CI: 2.03–9.81), volume (MD = 1,069.37 mm3, 95%CI: 1,025.75–1,112.99), vacuole sign (OR = 6.15, 95%CI: 2.70–14.01), CTR ≥0.5 (OR = 7.24, 95%CI: 3.35–15.65), vascular type [types III and IV] (OR = 13.62, 95%CI: 8.85–20.94), pleural indentation (OR = 6.92, 95%CI: 2.69–17.82), age (MD = 4.18years, 95%CI: 1.70–6.65), and mGGN (OR = 3.62, 95%CI: 2.36–5.56) were risk factors for infiltration of ground-glass nodules. The overall risk of bias in the methodological quality evaluation of the included studies was small, and the AUC value of the model was 0.736–0.977.Conclusion: The included model has a good predictive performance for the invasion of ground-glass nodules. The independent risk factors included in the model can help medical workers to identify the high-risk groups of invasive lung cancer in ground-glass nodules in time and improve the prognosis.
- 29 January 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1477730
Open AccessThe infiltration risk prediction models by logistic regression for ground-glass pulmonary nodules: a systematic review and meta-analysis
Methods: CNKI, Wanfang, VIP, Sinomed, Pubmed, Web of Science, Embase, and other databases were searched. The retrieval time was from the establishment of the database to January 31, 2024. We included all predictive models for the invasion of ground-glass pulmonary nodules established. The modeling group was patients with a pathological diagnosis of ground-glass pulmonary nodules. Two researchers screened the literature, established an Excel table for information extraction, used SPSS 25.0 to perform frequency statistics of each independent risk factor, and used Revman 5.4 software for meta-analysis.Results: A total of 29 articles were included, involving 30 independent risk factors, with a cumulative frequency of 99 times. There were 16 risk factors with a frequency of ≥2 times, a total of 85 times, accounting for 85.86%. The meta-analysis showed the following: average CT value (MD = 75.57 HU, 95%CI: 44.40–106.75), maximum diameter (MD = 4.99 mm, 95%CI: 4.22–5.77), vascular convergence sign (OR = 11.16, 95%CI: 6.71–18.56), lobulation sign (OR = 3.80, 95%CI: 1.59–9.09), average diameter (MD = 4.46 mm, 95%CI: 3.44–5.48), maximum CT value (MD = 112.52 HU, 95%CI: 8.08–216.96), spiculation sign (OR = 4.46, 95%CI: 2.03–9.81), volume (MD = 1,069.37 mm3, 95%CI: 1,025.75–1,112.99), vacuole sign (OR = 6.15, 95%CI: 2.70–14.01), CTR ≥0.5 (OR = 7.24, 95%CI: 3.35–15.65), vascular type [types III and IV] (OR = 13.62, 95%CI: 8.85–20.94), pleural indentation (OR = 6.92, 95%CI: 2.69–17.82), age (MD = 4.18years, 95%CI: 1.70–6.65), and mGGN (OR = 3.62, 95%CI: 2.36–5.56) were risk factors for infiltration of ground-glass nodules. The overall risk of bias in the methodological quality evaluation of the included studies was small, and the AUC value of the model was 0.736–0.977.Conclusion: The included model has a good predictive performance for the invasion of ground-glass nodules. The independent risk factors included in the model can help medical workers to identify the high-risk groups of invasive lung cancer in ground-glass nodules in time and improve the prognosis.
- Open Access
- 16 October 2024
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 15, 1487550
The interaction effects between depression and sleep status on asthma: a national cross-sectional study
Background: Asthma, depression, and sleep problems are three significant public health issues that are closely interrelated. This study aims to explore the relationship between depression, sleep status and asthma, as well as the potential interaction among these conditions and their effects on asthma.Method: This cross-sectional study utilized data from the 2005-2008 National Health and Nutritional Examination Survey, including information on asthma, depression, sleep status and confounding factors. Multivariate logistic regression analyses were conducted to investigate the relationship between depression, sleep status, and asthma. Subgroup analyses were conducted to test the p-interaction between depression and each stratified variable. Additionally, both multiplicative and additive approaches were employed to assess the interaction between depression and sleep status on asthma, as well as to quantify their combined effects.Results: A total of 8,327 participants (mean age 46.53 years) were included in this study. Compared to the individuals without depression, those with depression have an increased risk of asthma [Odds ratio (OR) = 1.57, 95% Confidence interval (CI) = 1.22-2.03], and an increase in the severity of depressive symptoms is associated with a higher risk of developing asthma. Additionally, poor sleep quality, sleep disorders, and insufficient sleep was associated with an increased risk of asthma. Effect modification was observed between depression and PIR status, smoking status, and sleep disorders in relation to asthma (p-interaction <0.05). Moreover, we found a positive interaction between severe depression and excessive sleep (OR = 29.07, 95% CI = 3.24-260.38). Furthermore, we observed the quantitative additive interaction indicators between moderately severe depression and insufficient sleep [Relative excess risk due to interaction (RERI) = 1.63, 95%CI = 0.18-3.83; Attributable proportion (AP) = 0.51, 95%CI = 0.15-0.87; Synergy index (SI) = 3.92, 95%CI = 1.65-23.50] influencing asthma risk.Conclusion: Our study revealed distinct associations between depression, the severity of depressive symptoms, poor sleep quality, sleep disorders, and insufficient sleep with asthma. Additionally, there was an interaction between moderately severe depression and insufficient sleep on asthma. Psychological and sleep assessment are essential in asthma management. Clinicians should consider the potential risk of depression and sleep problems in asthma patients and intervene. Further longitudinal research is needed to better understand the pathophysiological mechanisms behind the interactions between asthma, depression, and sleep problems.
- 16 October 2024
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 15, 1487550
Open AccessThe interaction effects between depression and sleep status on asthma: a national cross-sectional study
Background: Asthma, depression, and sleep problems are three significant public health issues that are closely interrelated. This study aims to explore the relationship between depression, sleep status and asthma, as well as the potential interaction among these conditions and their effects on asthma.Method: This cross-sectional study utilized data from the 2005-2008 National Health and Nutritional Examination Survey, including information on asthma, depression, sleep status and confounding factors. Multivariate logistic regression analyses were conducted to investigate the relationship between depression, sleep status, and asthma. Subgroup analyses were conducted to test the p-interaction between depression and each stratified variable. Additionally, both multiplicative and additive approaches were employed to assess the interaction between depression and sleep status on asthma, as well as to quantify their combined effects.Results: A total of 8,327 participants (mean age 46.53 years) were included in this study. Compared to the individuals without depression, those with depression have an increased risk of asthma [Odds ratio (OR) = 1.57, 95% Confidence interval (CI) = 1.22-2.03], and an increase in the severity of depressive symptoms is associated with a higher risk of developing asthma. Additionally, poor sleep quality, sleep disorders, and insufficient sleep was associated with an increased risk of asthma. Effect modification was observed between depression and PIR status, smoking status, and sleep disorders in relation to asthma (p-interaction <0.05). Moreover, we found a positive interaction between severe depression and excessive sleep (OR = 29.07, 95% CI = 3.24-260.38). Furthermore, we observed the quantitative additive interaction indicators between moderately severe depression and insufficient sleep [Relative excess risk due to interaction (RERI) = 1.63, 95%CI = 0.18-3.83; Attributable proportion (AP) = 0.51, 95%CI = 0.15-0.87; Synergy index (SI) = 3.92, 95%CI = 1.65-23.50] influencing asthma risk.Conclusion: Our study revealed distinct associations between depression, the severity of depressive symptoms, poor sleep quality, sleep disorders, and insufficient sleep with asthma. Additionally, there was an interaction between moderately severe depression and insufficient sleep on asthma. Psychological and sleep assessment are essential in asthma management. Clinicians should consider the potential risk of depression and sleep problems in asthma patients and intervene. Further longitudinal research is needed to better understand the pathophysiological mechanisms behind the interactions between asthma, depression, and sleep problems.
- Open Access
- 16 March 2021
- Published by Crimson Publishers in Novel Approaches in Cancer Study
- Vol. 5 (5) , 550-552
A Case Report: Traditional Chinese Medicine Treatment in the Management of Exudative Infiltration Related to post-Cryoablation for Multiple Pulmonary Nodules
- 16 March 2021
- Published by Crimson Publishers in Novel Approaches in Cancer Study
- Vol. 5 (5) , 550-552
Open AccessA Case Report: Traditional Chinese Medicine Treatment in the Management of Exudative Infiltration Related to post-Cryoablation for Multiple Pulmonary Nodules
- Open Access
- 1 March 2020
- Published by World Scientific Pub Co Pte Ltd in Traditional Medicine and Modern Medicine
- Vol. 03 (01) , 65-69
The clinical application of a traditional Chinese medicine prescription issued by Professor Liangduo Jiang in the prevention of coronavirus disease 2019 (COVID-19)
Objective: To summarize the clinical experience of Professor Liangduo Jiang in the prevention and control of the new coronavirus disease COVID-19. Methods: Between January 2020 and February 2020, 87 subjects who have had contact with patients tested positive for COVID-19 in an isolated observation site in Tianjin were given the Chinese medicine prescription for prevention prescribed by Professor Liangduo Jiang continuously for three days. Their basic information, clinical manifestations and medication adherence were statistically analyzed, and the clinical manifestations, temperature changes and infection status after medication were summarized. Results: After the 14-day isolation observation period, only one patient who had close contact with confirmed patients developed a positive test for COVID-19 after taking the preventive Chinese medicine prescription, with the infection rate of 1.149%. Conclusion: The preventive treatment by Professor Liangduo Jiang is effective in the prevention and control of the epidemic.
- 1 March 2020
- Published by World Scientific Pub Co Pte Ltd in Traditional Medicine and Modern Medicine
- Vol. 03 (01) , 65-69
Open AccessThe clinical application of a traditional Chinese medicine prescription issued by Professor Liangduo Jiang in the prevention of coronavirus disease 2019 (COVID-19)
Objective: To summarize the clinical experience of Professor Liangduo Jiang in the prevention and control of the new coronavirus disease COVID-19. Methods: Between January 2020 and February 2020, 87 subjects who have had contact with patients tested positive for COVID-19 in an isolated observation site in Tianjin were given the Chinese medicine prescription for prevention prescribed by Professor Liangduo Jiang continuously for three days. Their basic information, clinical manifestations and medication adherence were statistically analyzed, and the clinical manifestations, temperature changes and infection status after medication were summarized. Results: After the 14-day isolation observation period, only one patient who had close contact with confirmed patients developed a positive test for COVID-19 after taking the preventive Chinese medicine prescription, with the infection rate of 1.149%. Conclusion: The preventive treatment by Professor Liangduo Jiang is effective in the prevention and control of the epidemic.
- Open Access
- 16 September 2019
- Published by Spandidos Publications in Oncology Letters
- Vol. 18 (5) , 5185-5196
Screening and identification of key biomarkers in lung squamous cell carcinoma by bioinformatics analysis
The high mortality rate of lung squamous cell carcinoma (LUSC) is in part due to the lack of early detection of its biomarkers. The identification of key molecules involved in LUSC is therefore required to improve clinical diagnosis and treatment outcomes. The present study used the microarray datasets GSE31552, GSE6044 and GSE12428 from the Gene Expression Omnibus database to identify differentially expressed genes (DEGs). Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) enrichment analyses were conducted to construct the protein‑protein interaction network of DEGs and hub genes module using STRING and Cytoscape. The 67 DEGs identified consisted of 42 upregulated genes and 25 downregulated genes. The pathways predicted by KEGG and GO enrichment analyses of DEGs mainly included cell cycle, cell proliferation, glycolysis or gluconeogenesis, and tetrahydrofolate metabolic process. Further analysis of the University of California Santa Cruz and ONCOMINE databases identified 17 hub genes. Overall, the present study demonstrated hub genes that were closely associated with clinical tissue samples of LUSC, and identified TYMS, CCNB2 and RFC4 as potential novel biomarkers of LUSC. The findings of the present study contribute to an improved understanding of the molecular mechanisms of carcinogenesis and progression of LUSC, and assist with the identification of potential diagnostic and therapeutic targets of LUSC.
- 16 September 2019
- Published by Spandidos Publications in Oncology Letters
- Vol. 18 (5) , 5185-5196
Open AccessScreening and identification of key biomarkers in lung squamous cell carcinoma by bioinformatics analysis
The high mortality rate of lung squamous cell carcinoma (LUSC) is in part due to the lack of early detection of its biomarkers. The identification of key molecules involved in LUSC is therefore required to improve clinical diagnosis and treatment outcomes. The present study used the microarray datasets GSE31552, GSE6044 and GSE12428 from the Gene Expression Omnibus database to identify differentially expressed genes (DEGs). Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) enrichment analyses were conducted to construct the protein‑protein interaction network of DEGs and hub genes module using STRING and Cytoscape. The 67 DEGs identified consisted of 42 upregulated genes and 25 downregulated genes. The pathways predicted by KEGG and GO enrichment analyses of DEGs mainly included cell cycle, cell proliferation, glycolysis or gluconeogenesis, and tetrahydrofolate metabolic process. Further analysis of the University of California Santa Cruz and ONCOMINE databases identified 17 hub genes. Overall, the present study demonstrated hub genes that were closely associated with clinical tissue samples of LUSC, and identified TYMS, CCNB2 and RFC4 as potential novel biomarkers of LUSC. The findings of the present study contribute to an improved understanding of the molecular mechanisms of carcinogenesis and progression of LUSC, and assist with the identification of potential diagnostic and therapeutic targets of LUSC.
- Open Access
- 3 January 2019
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2019, 1-13
Yangyin Yiqi Mixture Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats through Inhibiting TGF-1/Smad Pathway and Epithelial to Mesenchymal TransitionObjective. The aim of the current study was to investigate the protective effect of Yangyin Yiqi Mixture (YYYQ) on Bleomycin-induced pulmonary fibrosis in rats based on TGF-β1/Smad signal pathway and epithelial to mesenchymal transition (EMT). Methods. 120 Wistar rats were randomly divided into six groups: control group, BLM group, BLM + Pred group, BLM+YYYQ-L group, BLM+YYYQ-M group, and BLM+YYYQ-H group. Rats were given an intratracheal instillation of 3 mg/kg BLM to establish the pulmonary fibrosis model and followed by different dosages of YYYQ (11, 22, 44g/kg, via intragastric gavage) or prednisone soluble (4.2mg/kg, via intragastric gavage) or water. After 14 days and 28 days, tissue sections were stained with hematoxylin-eosin and Masson’s trichrome to observe histopathological changes. Protein levels of TGF-β1, CTGF, Interleukin 18, and hydroxyproline were detected by ELISA method, and mRNA expressions of TGF-β1, TβRI, TβRII, Smad3, Smad7, α-SMA, E-cadherin, laminin, and collagen I were detected by RT-PCR. Results. TGF-β1, CTGF, Interleukin 18, and hydroxyproline levels and mRNA expression of TGF-β1, TβRI, TβRII, Smad3, α-SMA, laminin, and collagen I were significantly increased (p p β1, CTGF, hydroxyproline contents, and mRNA expression of TGF-β1, TβRI, TβRII, Smad3, α-SMA, laminin, and collagen I and upregulated mRNA levels of Smad7 and E-cadherin significantly (p p p Conclusion. These results showed that YYYQ has the potential of ameliorating the progression of pulmonary fibrosis, and the mechanism may be related to suppressing TGF-β1/Smad signal pathway and EMT in BLM-induced pulmonary fibrosis of rats.
- 3 January 2019
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2019, 1-13
Open AccessYangyin Yiqi Mixture Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats through Inhibiting TGF-1/Smad Pathway and Epithelial to Mesenchymal TransitionObjective. The aim of the current study was to investigate the protective effect of Yangyin Yiqi Mixture (YYYQ) on Bleomycin-induced pulmonary fibrosis in rats based on TGF-β1/Smad signal pathway and epithelial to mesenchymal transition (EMT). Methods. 120 Wistar rats were randomly divided into six groups: control group, BLM group, BLM + Pred group, BLM+YYYQ-L group, BLM+YYYQ-M group, and BLM+YYYQ-H group. Rats were given an intratracheal instillation of 3 mg/kg BLM to establish the pulmonary fibrosis model and followed by different dosages of YYYQ (11, 22, 44g/kg, via intragastric gavage) or prednisone soluble (4.2mg/kg, via intragastric gavage) or water. After 14 days and 28 days, tissue sections were stained with hematoxylin-eosin and Masson’s trichrome to observe histopathological changes. Protein levels of TGF-β1, CTGF, Interleukin 18, and hydroxyproline were detected by ELISA method, and mRNA expressions of TGF-β1, TβRI, TβRII, Smad3, Smad7, α-SMA, E-cadherin, laminin, and collagen I were detected by RT-PCR. Results. TGF-β1, CTGF, Interleukin 18, and hydroxyproline levels and mRNA expression of TGF-β1, TβRI, TβRII, Smad3, α-SMA, laminin, and collagen I were significantly increased (p p β1, CTGF, hydroxyproline contents, and mRNA expression of TGF-β1, TβRI, TβRII, Smad3, α-SMA, laminin, and collagen I and upregulated mRNA levels of Smad7 and E-cadherin significantly (p p p Conclusion. These results showed that YYYQ has the potential of ameliorating the progression of pulmonary fibrosis, and the mechanism may be related to suppressing TGF-β1/Smad signal pathway and EMT in BLM-induced pulmonary fibrosis of rats.
- Open Access
- 1 January 2018
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2018 (1) , 8903021
The Influence of BuqiHuoxueTongluo Formula on Histopathology and Pulmonary Function Test in Bleomycin‐Induced Idiopathic Pulmonary Fibrosis in Rats
BuqiHuoxueTongluo Formula (BHTF) is an effective herbal prescription based on traditional Chinese medicine for idiopathic pulmonary fibrosis (IPF). The aim of this study was to elucidate the influence of BHTF on induced IPF model through the aspect of histopathology and pulmonary function test. Wistar rats with bleomycin‐induced IPF were given BHTF via intragastric gavage. After 14 days and 28 days of treatment, respectively, on these two time points, we first performed pulmonary function test, performed ventilation measure, and traced the Pressure‐Volume Loop under anesthesia. Then, rats were sacrificed for hematoxylin‐eosin and Masson’s trichrome staining, immunohistochemistry staining of TGF‐β1 and α‐SMA, and observation through transmission electron microscope. BHTF reduced infiltration of inflammation cells, collagen deposition, and fibrosis proliferation in pulmonary mesenchyme, inhibited the expression of TGF‐β1 and α‐SMA, and avoided the abnormality of ultrastructure and quantities of lamellar bodies. It also ameliorated the parameters of FVC, MVV, PEF, FEF25, and Cdyn, maintained the shape of the Pressure‐Volume Loop, and improved hysteresis. BHFT relieved the histopathologic changes, improved ventilation function, compliance, and work of breathing, meliorated the capacity and elasticity of the lungs, and stabilized the alveolar surface tension. Further speaking, it had a potential impact on the secretion of pulmonary surfactant.
- 1 January 2018
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2018 (1) , 8903021
Open AccessThe Influence of BuqiHuoxueTongluo Formula on Histopathology and Pulmonary Function Test in Bleomycin‐Induced Idiopathic Pulmonary Fibrosis in Rats
BuqiHuoxueTongluo Formula (BHTF) is an effective herbal prescription based on traditional Chinese medicine for idiopathic pulmonary fibrosis (IPF). The aim of this study was to elucidate the influence of BHTF on induced IPF model through the aspect of histopathology and pulmonary function test. Wistar rats with bleomycin‐induced IPF were given BHTF via intragastric gavage. After 14 days and 28 days of treatment, respectively, on these two time points, we first performed pulmonary function test, performed ventilation measure, and traced the Pressure‐Volume Loop under anesthesia. Then, rats were sacrificed for hematoxylin‐eosin and Masson’s trichrome staining, immunohistochemistry staining of TGF‐β1 and α‐SMA, and observation through transmission electron microscope. BHTF reduced infiltration of inflammation cells, collagen deposition, and fibrosis proliferation in pulmonary mesenchyme, inhibited the expression of TGF‐β1 and α‐SMA, and avoided the abnormality of ultrastructure and quantities of lamellar bodies. It also ameliorated the parameters of FVC, MVV, PEF, FEF25, and Cdyn, maintained the shape of the Pressure‐Volume Loop, and improved hysteresis. BHFT relieved the histopathologic changes, improved ventilation function, compliance, and work of breathing, meliorated the capacity and elasticity of the lungs, and stabilized the alveolar surface tension. Further speaking, it had a potential impact on the secretion of pulmonary surfactant.